hVIVO plc (AIM:HVO)
London · Delayed Price · Currency is GBP · Price in GBX 6.69
+0.14 (2.08%)
Aug 17, 2026, 4:23 PM GMT
hVIVO Market Cap
hVIVO has a market cap or net worth of 45 million as of August 17, 2026. Its market cap has decreased by -38.47% in one year.
Market Cap
45.00M
Enterprise Value
45.49M
Revenue
49.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.69
ChartMarket Cap Chart
Since July 1, 2019, hVIVO's market cap has increased from 17.24M to 45.00M, an increase of 161.05%. That is a compound annual growth rate of 14.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 45.00M | 4.98% |
| Dec 31, 2025 | 42.86M | -69.27% |
| Dec 31, 2024 | 139.48M | -13.68% |
| Dec 29, 2023 | 161.59M | 140.84% |
| Dec 30, 2022 | 67.09M | -56.52% |
| Dec 31, 2021 | 154.31M | -10.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scancell Holdings | 116.37M |
| Faron Pharmaceuticals Oy | 88.84M |
| 4basebio | 85.46M |
| Bioventix | 78.37M |
| Ondine Biomedical | 71.44M |
| Poolbeg Pharma | 64.89M |
| Hemogenyx Pharmaceuticals | 41.17M |
| Sareum Holdings | 36.72M |